+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Unasyn"

Unasyn - API Insight, 2022 - Product Thumbnail Image

Unasyn - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Unasyn- Drug Insight, 2019 - Product Thumbnail Image

Unasyn- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Unasyn is a brand of antibiotics used to treat bacterial infections of the central nervous system (CNS). It is a combination of ampicillin and sulbactam, two antibiotics that work together to fight bacteria. Unasyn is used to treat bacterial meningitis, brain abscesses, and other CNS infections. It is also used to treat infections of the skin, urinary tract, and respiratory tract. Unasyn is available in both intravenous and oral forms. The Unasyn market is a subset of the larger Central Nervous System Drugs market. This market includes a variety of drugs used to treat neurological disorders, such as epilepsy, Parkinson's disease, and Alzheimer's disease. It also includes drugs used to treat psychiatric disorders, such as depression and anxiety. Some companies in the Unasyn market include Pfizer, Merck, and GlaxoSmithKline. These companies produce and market Unasyn and other CNS drugs. Other companies in the market include AstraZeneca, Novartis, and Sanofi. Show Less Read more